Lunit Inc. — Investor Relations & Filings

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.